Despite radiation exposure and fracture risk, pricey QCT bone density scans are rising in popularity

MedPage Today reported April 13 that quantitative computed tomography (QCT) bone density scans for osteoporosis screening are on the rise, in spite of their high costs and potentially questionable accuracy. 

Dual-energy X-ray absorptiometry (DXA) has long been the gold standard for osteoporosis screening. But now, thousands of patients may be inappropriately undergoing bone mineral density studies via quantitative computed tomography — which may be less accurate and more expensive, with far higher radiation exposure,” author Cheryl Clark writes. 

In examining possible reasons behind the rise in QCT orders — of which nearly half come from just four states — the article notes that reimbursement rates for DXA were cut drastically in 2007 under the Deficit Reduction Act, and that some clinicians have decommissioned their DXA scanners since then. 

Jessica Kania is a digital editor who has worked across the Innovate Healthcare brands, including Radiology Business, Health Imaging, AI in Healthcare and Cardiovascular Business. She also has vast experience working on custom content projects focused on technology innovation, clinical excellence, operational efficiency and improving financial performance in healthcare.  

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.